BIO

Kate obtained her 4-year BSc in Neuroscience at Aston University in 2020. The third year of her degree was spent in the Woodhall Laboratory exploring the anticonvulsant properties of experimental compounds, with an additional focus on how anti-epileptic drugs affect neuronal network activity in a healthy brain. Her final year dissertation project’s aim was to design a study investigating changes in GABAA and NMDA receptor expression during status epilepticus.

Kate is currently a PhD student in the Graphene NOWNANO CDT at the University of Manchester, her project within the Nanomedicine lab is focused on the use of nanotechnology to investigate epileptogenesis in glioblastoma.